Literature DB >> 14574644

Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy.

Jan Senderek1, Carsten Bergmann, Claudia Stendel, Jutta Kirfel, Nathalie Verpoorten, Peter De Jonghe, Vincent Timmerman, Roman Chrast, Mark H G Verheijen, Greg Lemke, Esra Battaloglu, Yesim Parman, Sevim Erdem, Ersin Tan, Haluk Topaloglu, Andreas Hahn, Wolfgang Müller-Felber, Nicolò Rizzuto, Gian Maria Fabrizi, Manfred Stuhrmann, Sabine Rudnik-Schöneborn, Stephan Züchner, J Michael Schröder, Eckhard Buchheim, Volker Straub, Jörg Klepper, Kathrin Huehne, Bernd Rautenstrauss, Reinhard Büttner, Eva Nelis, Klaus Zerres.   

Abstract

Charcot-Marie-Tooth disease type 4C (CMT4C) is a childhood-onset demyelinating form of hereditary motor and sensory neuropathy associated with an early-onset scoliosis and a distinct Schwann cell pathology. CMT4C is inherited as an autosomal recessive trait and has been mapped to a 13-cM linkage interval on chromosome 5q23-q33. By homozygosity mapping and allele-sharing analysis, we refined the CMT4C locus to a suggestive critical region of 1.7 Mb. We subsequently identified mutations in an uncharacterized transcript, KIAA1985, in 12 families with autosomal recessive neuropathy. We observed eight distinct protein-truncating mutations and three nonconservative missense mutations affecting amino acids conserved through evolution. In all families, we identified a mutation on each disease allele, either in the homozygous or in the compound heterozygous state. The CMT4C gene is strongly expressed in neural tissues, including peripheral nerve tissue. The translated protein defines a new protein family of unknown function with putative orthologues in vertebrates. Comparative sequence alignments indicate that members of this protein family contain multiple SH3 and TPR domains that are likely involved in the formation of protein complexes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14574644      PMCID: PMC1180490          DOI: 10.1086/379525

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom.

Authors:  L Kalaydjieva; D Gresham; R Gooding; L Heather; F Baas; R de Jonge; K Blechschmidt; D Angelicheva; D Chandler; P Worsley; A Rosenthal; R H King; P K Thomas
Journal:  Am J Hum Genet       Date:  2000-05-30       Impact factor: 11.025

2.  A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease.

Authors:  A Guilbot; A Williams; N Ravisé; C Verny; A Brice; D L Sherman; P J Brophy; E LeGuern; V Delague; C Bareil; A Mégarbané; M Claustres
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

3.  The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold.

Authors:  R Stoll; C Renner; M Zweckstetter; M Brüggert; D Ambrosius; S Palme; R A Engh; M Golob; I Breibach; R Buettner; W Voelter; T A Holak; A K Bosserhoff
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

4.  Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21.

Authors:  Rachel V Baxter; Kamel Ben Othmane; Julie M Rochelle; Jason E Stajich; Christine Hulette; Susan Dew-Knight; Faycal Hentati; Mongi Ben Hamida; S Bel; Judy E Stenger; John R Gilbert; Margaret A Pericak-Vance; Jeffery M Vance
Journal:  Nat Genet       Date:  2001-12-17       Impact factor: 38.330

5.  Homozygosity mapping of an autosomal recessive form of demyelinating Charcot-Marie-Tooth disease to chromosome 5q23-q33.

Authors:  E LeGuern; A Guilbot; M Kessali; N Ravisé; J Tassin; T Maisonobe; D Grid; A Brice
Journal:  Hum Mol Genet       Date:  1996-10       Impact factor: 6.150

6.  Periaxin mutations cause recessive Dejerine-Sottas neuropathy.

Authors:  C F Boerkoel; H Takashima; P Stankiewicz; C A Garcia; S M Leber; L Rhee-Morris; J R Lupski
Journal:  Am J Hum Genet       Date:  2000-12-15       Impact factor: 11.025

7.  Autosomal recessive hereditary motor and sensory neuropathy.

Authors:  P K Thomas
Journal:  Curr Opin Neurol       Date:  2000-10       Impact factor: 5.710

8.  Genetic, cytogenetic and physical refinement of the autosomal recessive CMT linked to 5q31-q33: exclusion of candidate genes including EGR1.

Authors:  A Guilbot; N Ravisé; A Bouhouche; P Coullin; N Birouk; T Maisonobe; T Kuntzer; C Vial; D Grid; A Brice; E LeGuern
Journal:  Eur J Hum Genet       Date:  1999-12       Impact factor: 4.246

9.  Dominant expression of a novel splice variant of caspase-8 in human peripheral blood lymphocytes.

Authors:  T Horiuchi; D Himeji; H Tsukamoto; S Harashima; C Hashimura; K Hayashi
Journal:  Biochem Biophys Res Commun       Date:  2000-06-16       Impact factor: 3.575

10.  Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death.

Authors:  C D Bingle; R W Craig; B M Swales; V Singleton; P Zhou; M K Whyte
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

View more
  64 in total

1.  Peripheral neuropathies: whole genome sequencing identifies causal variants in CMT.

Authors:  Stephan Züchner
Journal:  Nat Rev Neurol       Date:  2010-08       Impact factor: 42.937

2.  Founder mutations in NDRG1 and HK1 genes are common causes of inherited neuropathies among Roma/Gypsies in Slovakia.

Authors:  Dana Gabrikova; Martin Mistrik; Jarmila Bernasovska; Alexandra Bozikova; Regina Behulova; Iveta Tothova; Sona Macekova
Journal:  J Appl Genet       Date:  2013-08-31       Impact factor: 3.240

3.  Compound heterozygous mutations of SH3TC2 in Charcot-Marie-Tooth disease type 4C patients.

Authors:  Ah Jin Lee; Soo Hyun Nam; Jin-Mo Park; Sumaira Kanwal; Yu Jin Choi; Hyun Jung Lee; Kyung Suk Lee; Ji Eun Lee; Jin-Sung Park; Byung-Ok Choi; Ki Wha Chung
Journal:  J Hum Genet       Date:  2019-06-21       Impact factor: 3.172

Review 4.  A review of genetic counseling for Charcot Marie Tooth disease (CMT).

Authors:  Carly E Siskind; Seema Panchal; Corrine O Smith; Shawna M E Feely; Joline C Dalton; Alice B Schindler; Karen M Krajewski
Journal:  J Genet Couns       Date:  2013-04-21       Impact factor: 2.537

5.  Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach.

Authors:  Magdalena Zimoń; Esra Battaloğlu; Yesim Parman; Sevim Erdem; Jonathan Baets; Els De Vriendt; Derek Atkinson; Leonardo Almeida-Souza; Tine Deconinck; Burcak Ozes; Dirk Goossens; Sebahattin Cirak; Philip Van Damme; Mohammad Shboul; Thomas Voit; Lionel Van Maldergem; Bernard Dan; Mohammed S El-Khateeb; Velina Guergueltcheva; Eduardo Lopez-Laso; Nathalie Goemans; Amira Masri; Stephan Züchner; Vincent Timmerman; Haluk Topaloğlu; Peter De Jonghe; Albena Jordanova
Journal:  Neurogenetics       Date:  2014-09-18       Impact factor: 2.660

6.  Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4).

Authors:  Giuseppe Piscosquito; Paola Saveri; Stefania Magri; Claudia Ciano; Claudia Gandioli; Michela Morbin; Daniela D Bella; Isabella Moroni; Franco Taroni; Davide Pareyson
Journal:  J Peripher Nerv Syst       Date:  2016-09       Impact factor: 3.494

Review 7.  [Genetics of neuropathies].

Authors:  B Gess; A Schirmacher; P Young
Journal:  Nervenarzt       Date:  2013-02       Impact factor: 1.214

8.  Autosomal recessive forms of Charcot-Marie-Tooth disease.

Authors:  J M Vallat; D Grid; C Magdelaine; F Sturtz; M Tazir
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

Review 9.  Diagnosis of Charcot-Marie-Tooth disease.

Authors:  Isabel Banchs; Carlos Casasnovas; Antonia Albertí; Laura De Jorge; Mónica Povedano; Jordi Montero; Juan Antonio Martínez-Matos; Victor Volpini
Journal:  J Biomed Biotechnol       Date:  2009-10-08

10.  Charcot-marie-tooth disease: seventeen causative genes.

Authors:  Jung-Hwa Lee; Byung-Ok Choi
Journal:  J Clin Neurol       Date:  2006-06-20       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.